PT - JOURNAL ARTICLE AU - Pramod Kumar AU - Rajesh Pandey AU - Pooja Sharma AU - Mahesh S Dhar AU - A Vivekanand AU - Bharathram Uppili AU - Himanshu Vashisht AU - Saruchi Wadhwa AU - Nishu Tyagi AU - Saman Fatihi AU - Uma Sharma AU - Priyanka Singh AU - Hemlata Lall AU - Meena Datta AU - Poonam Gupta AU - Nidhi Saini AU - Aarti Tewari AU - Bibhash Nandi AU - Dhirendra Kumar AU - Satyabrata Bag AU - Deepanshi AU - Surabhi Rathore AU - Nidhi Jatana AU - Varun Jaiswal AU - Hema Gogia AU - Preeti Madan AU - Simrita Singh AU - Prateek Singh AU - Debasis Dash AU - Manju Bala AU - Sandhya Kabra AU - Sujeet Singh AU - Mitali Mukerji AU - Lipi Thukral AU - Mohammed Faruq AU - Anurag Agrawal AU - Partha Rakshit TI - Integrated genomic view of SARS-CoV-2 in India AID - 10.1101/2020.06.04.128751 DP - 2020 Jan 01 TA - bioRxiv PG - 2020.06.04.128751 4099 - http://biorxiv.org/content/early/2020/06/04/2020.06.04.128751.short 4100 - http://biorxiv.org/content/early/2020/06/04/2020.06.04.128751.full AB - India first detected SARS-CoV-2, causal agent of COVID-19 in late January-2020, imported from Wuhan, China. March-2020 onwards; importation of cases from rest of the countries followed by seeding of local transmission triggered further outbreaks in India. We used ARTIC protocol based tiling amplicon sequencing of SARS-CoV-2 (n=104) from different states of India using a combination of MinION and MinIT from Oxford Nanopore Technology to understand introduction and local transmission. The analyses revealed multiple introductions of SARS-CoV-2 from Europe and Asia following local transmission. The most prevalent genomes with patterns of variance (confined in a cluster) remain unclassified, here, proposed as A4-clade based on its divergence within A-cluster. The viral haplotypes may link their persistence to geo-climatic conditions and host response. Despite the effectiveness of non-therapeutic interventions in India, multipronged strategies including molecular surveillance based on real-time viral genomic data is of paramount importance for a timely management of the pandemic.Competing Interest StatementThe authors have declared no competing interest.